High materiality8/10
BridgeBio Pharma price target raised to $110 from $96 at Mizuho
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Mizuho Securities raises BBIO target to 110; current price 76.59; implied upside ~43%.
- Mizuho raises BBIO target to 110
- Current price 76.59; upside ~43%
Key facts
- 01
Target: $110
- 02
Posted price: $76.59
- 03
Analyst firm: Mizuho Securities
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.